Tocopherol
Sponsors
University of Colorado, Denver, French National Agency for Research on AIDS and Viral Hepatitis, Hadassah Medical Organization, University of Washington, Ryazan State Medical University
Conditions
Avascular NecrosisBisphosphonate-related Osteonecrosis of the JawDrug ToxicityEnd Stage Renal DiseaseFibrosisFibrosis SyndromeHead &Amp; Neck CancerHepatitis C, Chronic
Phase 2
13-Cis Retinoic Acid With or Without Vitamin E for Prevention of Lung Cancer
CompletedNCT00002586
Start: 1993-01-31End: 2005-12-31Updated: 2020-05-15
Tocopherol is a Novel Treatment for Cancer Related Mucositis
WithdrawnNCT00162526
Start: 2005-12-31Target: 30Updated: 2011-04-08
Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)
RecruitingNCT06494111
Start: 2025-02-13End: 2031-03-01Target: 295Updated: 2026-09-11
Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
RecruitingNCT06912763
Start: 2025-08-08End: 2031-07-31Target: 250Updated: 2026-07-24
Phase 3
Efficacy and Safety of Pentoxyphilline and Tocopherol on the Fibrosis in Patients With Chronic Hepatitis C
TerminatedNCT00119119
Start: 2002-02-28End: 2006-12-31Target: 100Updated: 2007-01-12
Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ)
Active, not recruitingNCT03040778
Start: 2018-04-01End: 2026-06-30Target: 100Updated: 2026-04-29
The Effect of Vitamin C and E Therapy on Restless Leg Syndrome in Patients With End Stage Renal Disease on Haemodialysis
NCT05350124
Start: 2022-11-30End: 2023-12-31Target: 160Updated: 2022-08-24